Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision indicator was updated from v3.5.4 to v3.5.5, marking a new version of the ClinicalTrials.gov study record.
    Difference
    0.0%
    Check dated 2026-06-08T04:18:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-17T10:26:59.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an informational site release rather than a change to the clinical trial content.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-18T13:40:14.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 removed and Revision: v3.5.0 added.
    Difference
    0.0%
    Check dated 2026-03-21T01:07:26.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:11.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.